165 related articles for article (PubMed ID: 26625723)
1. Qualitative insights into promotion of pharmaceutical products in Bangladesh: how ethical are the practices?
Mohiuddin M; Rashid SF; Shuvro MI; Nahar N; Ahmed SM
BMC Med Ethics; 2015 Dec; 16(1):80. PubMed ID: 26625723
[TBL] [Abstract][Full Text] [Related]
2. Pharmaceutical marketing strategies' influence on physicians' prescribing pattern in Lebanon: ethics, gifts, and samples.
Khazzaka M
BMC Health Serv Res; 2019 Jan; 19(1):80. PubMed ID: 30700295
[TBL] [Abstract][Full Text] [Related]
3. Influence of pharmaceutical promotion on prescribers in Jordan.
Altawalbeh SM; Ibrahim IA; Al-Shatnawi SF
Int J Clin Pharm; 2020 Apr; 42(2):744-755. PubMed ID: 32140917
[TBL] [Abstract][Full Text] [Related]
4. Drug promotion practices: A review.
Jacob NT
Br J Clin Pharmacol; 2018 Aug; 84(8):1659-1667. PubMed ID: 29349812
[TBL] [Abstract][Full Text] [Related]
5. [Case: bioethical disputes of the donations of the pharmaceutical companies to the health centers].
González-González A
Cuad Bioet; 2020; 31(103):423-427. PubMed ID: 33375807
[TBL] [Abstract][Full Text] [Related]
6. Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review.
Spurling GK; Mansfield PR; Montgomery BD; Lexchin J; Doust J; Othman N; Vitry AI
PLoS Med; 2010 Oct; 7(10):e1000352. PubMed ID: 20976098
[TBL] [Abstract][Full Text] [Related]
7. Attitudes and relationship between physicians and the pharmaceutical industry in a public general hospital in Lima, Peru.
De Ferrari A; Gentille C; Davalos L; Huayanay L; Malaga G
PLoS One; 2014; 9(6):e100114. PubMed ID: 24978481
[TBL] [Abstract][Full Text] [Related]
8. Drug promotional practices in Mumbai: a qualitative study.
Roy N; Madhiwalla N; Pai SA
Indian J Med Ethics; 2007; 4(2):57-61. PubMed ID: 18630221
[TBL] [Abstract][Full Text] [Related]
9. Extent of physician-pharmaceutical industry interactions in low- and middle-income countries: a systematic review.
Fadlallah R; Alkhaled L; Brax H; Nasser M; Rajabbik MH; Nass H; Kahale LA; Akl EA
Eur J Public Health; 2018 Apr; 28(2):224-230. PubMed ID: 29165586
[TBL] [Abstract][Full Text] [Related]
10. Prescribers and pharmaceutical representatives: why are we still meeting?
Fischer MA; Keough ME; Baril JL; Saccoccio L; Mazor KM; Ladd E; Von Worley A; Gurwitz JH
J Gen Intern Med; 2009 Jul; 24(7):795-801. PubMed ID: 19424764
[TBL] [Abstract][Full Text] [Related]
11. The attitude and acceptability towards medical promotional tools and their influence on physicians' prescribing practices in Jordan and Iraq: a cross-sectional study.
Ali KE; Naser AY; Al-Rousan R; Alwafi H; AbuAlhommos AK; Alsairafi ZK; Salawati EM; Samannodi M; Dairi MS
BMC Health Serv Res; 2022 Jan; 22(1):105. PubMed ID: 35078461
[TBL] [Abstract][Full Text] [Related]
12. Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review.
Fickweiler F; Fickweiler W; Urbach E
BMJ Open; 2017 Sep; 7(9):e016408. PubMed ID: 28963287
[TBL] [Abstract][Full Text] [Related]
13. Doping Doctors: The Influence of the Marketing Departments of Pharmaceutical Companies on Physician and Researcher Behavior in Japan.
Ichikawa I; Clayton EW
Account Res; 2016; 23(4):245-53. PubMed ID: 26829657
[No Abstract] [Full Text] [Related]
14. Guidelines, editors, pharma and the biological paradigm shift.
Singh AR; Singh SA
Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
[TBL] [Abstract][Full Text] [Related]
15. Does brand differentiate pharmaceuticals?
Bednarik J
Neuro Endocrinol Lett; 2005 Dec; 26(6):635-52. PubMed ID: 16380705
[TBL] [Abstract][Full Text] [Related]
16. Drug promotional activities in Nigeria: impact on the prescribing patterns and practices of medical practitioners and the implications.
Fadare JO; Oshikoya KA; Ogunleye OO; Desalu OO; Ferrario A; Enwere OO; Adeoti A; Sunmonu TA; Massele A; Baker A; Godman B
Hosp Pract (1995); 2018 Apr; 46(2):77-87. PubMed ID: 29426263
[TBL] [Abstract][Full Text] [Related]
17. Gifts and influence: Conflict of interest policies and prescribing of psychotropic medications in the United States.
King M; Bearman PS
Soc Sci Med; 2017 Jan; 172():153-162. PubMed ID: 27856120
[TBL] [Abstract][Full Text] [Related]
18. "But doctors do it...": nurses' views of gifts and information from the pharmaceutical industry.
Jutel A; Menkes DB
Ann Pharmacother; 2009 Jun; 43(6):1057-63. PubMed ID: 19470854
[TBL] [Abstract][Full Text] [Related]
19. Adherence of Drug Promotional Literatures Distributed by Pharmaceutical Companies to World Health Organization Ethical Criteria for Medicinal Drug Promotion.
Prasad P; Bajracharya SR; Deo S; Lamichhane S; Pradhan PMS; Ghimire R; Pokharel A
J Nepal Health Res Counc; 2019 Nov; 17(3):345-350. PubMed ID: 31735930
[TBL] [Abstract][Full Text] [Related]
20. Physician attitudes toward industry: a view across the specialties.
Korenstein D; Keyhani S; Ross JS
Arch Surg; 2010 Jun; 145(6):570-7. PubMed ID: 20566978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
